玻璃离子水门汀的临床研究。III. 侵蚀性病变。
The clinical development of the glass-ionomer cement. III. The erosion lesion.
作者信息
McLean J W, Wilson A D
出版信息
Aust Dent J. 1977 Jun;22(3):190-5. doi: 10.1111/j.1834-7819.1977.tb04487.x.
Abstract
A clinical trial of the glass-ionomer cement, ASPA IV, as a restorative material for erosion lesions is reported. The failure rate, in a three-year trial, was nine per cent; most failures occurring within the first few months after placement.
摘要
据报道，开展了一项关于玻璃离子水门汀ASPA IV作为侵蚀性病变修复材料的临床试验。在为期三年的试验中，失败率为9%；大多数失败发生在放置后的最初几个月内。
Zotero 插件